✦ LIBER ✦

Metastatic renal cell carcinoma to the orofacial region: A novel method to alleviate symptoms and control disease progression

✍ Scribed by Zaid Hamdoon; Waseem Jerjes; Tahwinder Upile; Sarah Akram; Colin Hopper

Book ID: 119344396
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 776 KB
Volume: 7
Category: Article
ISSN: 1572-1000
DOI: 10.1016/j.pdpdt.2010.08.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Time to disease progression to evaluate

Time to disease progression to evaluate a novel protein kinase C inhibitor, UCN-01, in renal cell carcinoma

✍ Brian I. Rini; Vivian Weinberg; Vanessa Shaw; Janet Scott; Robert Bok; John W. P 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

## Abstract ## BACKGROUND Renal cell carcinoma (RCC) is characterized by von Hippel‐Lindau gene inactivation and vascular endothelial growth factor (VEGF) overproduction. The mechanism of VEGF overproduction may involve protein kinase C (PKC) delta and zeta isoforms. UCN‐01 (7‐hydroxystaurosporine

7124 Association between time to disease

7124 Association between time to disease progression (TDP) endpoints and overall survival (OS) in patients with metastatic renal cell carcinoma (mRCC)

✍ Delea, T.; Khuu, A.; Kay, A.; Zheng, J.; Baladi, J.F. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB

A cost-effectiveness analysis of sunitin

A cost-effectiveness analysis of sunitinib in patients with metastatic renal cell carcinoma intolerant to or experiencing disease progression on immunotherapy: perspective of the Spanish National Health System

✍ L. Paz-Ares; J. G. Del Muro; E. Grande; S. Díaz 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB

The association of pre-treatment neutrop

The association of pre-treatment neutrophil to lymphocyte ratio with response rate, progression free survival and overall survival of patients treated with sunitinib for metastatic renal cell carcinoma

✍ Daniel Keizman; Maya Ish-Shalom; Peng Huang; Mario A. Eisenberger; Roberto Pili; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 310 KB

1838 WHEN TO PERFORM LYMPH NODE DISSECTI

1838 WHEN TO PERFORM LYMPH NODE DISSECTION IN RENAL CELL CARCINOMA PATIENTS: A NOVEL APPROACH TO PREOPERATIVELY ASSESS THE RISK OF LYMPH NODE INVASION AT SURGERY AND NODAL PROGRESSION DURING FOLLOW UP

✍ Capitanio, Umberto; Abdollah, Firas; Matloob, Rayan; Suardi, Nazareno; Gallina, 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 119 KB

953 When to perform lymph node dissectio

953 When to perform lymph node dissection in renal cell carcinoma patients: A novel approach to preoperatively assess the risk of lymph node invasion at surgery and nodal progression during follow up

✍ Capitanio, U.; Abdollah, F.; Matloob, R.; Gallina, A.; Pellucchi, F.; Russo, A.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 70 KB